Maria Stavrou

Title: Maria Stavrou: Innovator in Signalling Systems

Introduction

Maria Stavrou is a prominent inventor based in London, GB. She has made significant contributions to the field of biotechnology, particularly in the development of innovative signalling systems. Her work focuses on enhancing the functionality of chimeric antigen receptor (CAR) systems, which are crucial in therapeutic applications.

Latest Patents

Maria holds a patent for a novel signalling system. The invention provides a chimeric antigen receptor (CAR) system comprising a receptor component and a signalling component. The receptor component includes an antigen binding domain and a first binding domain, while the signalling component consists of a signalling domain and a second binding domain. This innovative design allows for the disruption of binding between the first and second binding domains in the presence of an agent, thereby controlling the signalling process. In the absence of the agent, the receptor and signalling components heterodimerize, leading to effective signalling upon antigen binding.

Career Highlights

Maria Stavrou is currently associated with Autolus Limited, where she continues to advance her research and development efforts. Her work has positioned her as a key player in the biotechnology sector, contributing to the development of cutting-edge therapies.

Collaborations

Some of her notable coworkers include Martin Pulé and Shaun Cordoba, who collaborate with her on various projects within the company.

Conclusion

Maria Stavrou's innovative work in signalling systems exemplifies the impact of biotechnology on modern medicine. Her contributions are paving the way for advancements in therapeutic applications, showcasing the importance of innovation in this field.